(Children's Hospital of Philadelphia) Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells.
from EurekAlert! - Technology, Engineering and Computer Science https://ift.tt/2XWfZCz
Thursday, March 14, 2019
Antibody-drug conjugate shows efficacy against cell surface protein in neuroblastoma
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.